COSTELLO ELLEN
COSTELLO ELLEN's purchase track record
COSTELLO ELLEN has no open-market purchases with a full 6 months of price history after it -- too few to call a track record yet.
| Purchase | Stock | Amount | 3 months | 6 months | S&P 500, 6 mo. |
|---|---|---|---|---|---|
| 5/12/2022 | DBD | $99K | pending | pending | — |
Computed by MarketWall from SEC Form 4 filings and daily closing prices (close on the purchase date to the close about 3 and 6 months later). Companies that have since delisted are not included. Past results, not investment advice.
Associated companies
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 12, 2026
Diebold Nixdorf partners stc pay Bahrain on digital‑physical services. Diebold Nixdorf announced a partnership with stc pay Bahrain to connect digital payment solutions with its physical financial service offerings. The collaboration aims to broaden the company’s reach in the Middle East by combining stc pay’s mobile platform with Diebold Nixdorf’s ATM and kiosk network. The firm also scheduled its 2026 third‑quarter investor call for Oct. 28, giving analysts an opportunity to discuss progress on converting its order backlog into cash.
Transaction History
| C | ▲ Buy | Grant | 1,263 | $0 | 1/2/2026 | View on chart |
| C | ▲ Buy | Grant | 2,118 | $0 | 1/2/2025 | View on chart |
| C | ▲ Buy | Grant | 24 | $2K | 1/2/2025 | View on chart |
| C | ▲ Buy | Grant | 494 | $35K | 1/2/2025 | View on chart |
| C | ▲ Buy | Grant | 724 | $51K | 1/2/2025 | View on chart |
| C | ▲ Buy | Grant | 832 | $51K | 10/1/2024 | View on chart |
| C | ▲ Buy | Grant | 27 | $2K | 10/1/2024 | View on chart |
| C | ▲ Buy | Grant | 555 | $34K | 10/1/2024 | View on chart |
| C | ▲ Buy | Grant | 829 | $51K | 7/1/2024 | View on chart |
| C | ▲ Buy | Grant | 512 | $32K | 7/1/2024 | View on chart |
| C | ▲ Buy | Grant | 25 | $2K | 7/1/2024 | View on chart |
| C | ▲ Buy | Grant | 1,151 | $71K | 4/1/2024 | View on chart |
| C | ▲ Buy | Grant | 25 | $2K | 4/1/2024 | View on chart |
| C | ▲ Buy | Grant | 497 | $31K | 4/1/2024 | View on chart |
| C | ▲ Buy | Grant | 1,388 | $71K | 1/2/2024 | View on chart |
| C | ▲ Buy | Grant | 518 | $27K | 1/2/2024 | View on chart |
| C | ▲ Buy | Grant | 61 | $3K | 1/2/2024 | View on chart |
| C | ▲ Buy | Grant | 2,923 | $0 | 1/2/2024 | View on chart |
| C | ▲ Buy | Grant | 1,746 | $71K | 10/1/2023 | View on chart |
| C | ▲ Buy | Grant | 75 | $3K | 10/1/2023 | View on chart |
| C | ▲ Buy | Grant | 621 | $25K | 10/1/2023 | View on chart |
| C | ▲ Buy | Grant | 1,469 | $68K | 7/1/2023 | View on chart |
| C | ▲ Buy | Grant | 63 | $3K | 7/1/2023 | View on chart |
| C | ▲ Buy | Grant | 506 | $23K | 7/1/2023 | View on chart |
| C | ▲ Buy | Grant | 1,447 | $66K | 4/1/2023 | View on chart |
| C | ▲ Buy | Grant | 489 | $22K | 4/1/2023 | View on chart |
| C | ▲ Buy | Grant | 63 | $3K | 4/1/2023 | View on chart |
| C | ▲ Buy | Grant | 3,353 | $0 | 1/3/2023 | View on chart |
| C | ▲ Buy | Grant | 1,446 | $66K | 1/1/2023 | View on chart |
| C | ▲ Buy | Grant | 441 | $20K | 1/1/2023 | View on chart |
| C | ▲ Buy | Grant | 54 | $2K | 1/1/2023 | View on chart |
| C | ▲ Buy | Grant | 1,347 | $66K | 10/1/2022 | View on chart |
| C | ▲ Buy | Grant | 392 | $19K | 10/1/2022 | View on chart |
| C | ▲ Buy | Grant | 49 | $2K | 10/1/2022 | View on chart |
| C | ▲ Buy | Grant | 1,324 | $66K | 7/1/2022 | View on chart |
| C | ▲ Buy | Grant | 368 | $18K | 7/1/2022 | View on chart |
| C | ▲ Buy | Grant | 48 | $2K | 7/1/2022 | View on chart |
| DBD | ▲ Buy | Open Market | 12,000 | $39K | 5/17/2022 | View on chart |
| DBD | ▲ Buy | Open Market | 25,000 | $60K | 5/12/2022 | View on chart |
| DBD | ▲ Buy | Grant | 30,928 | $0 | 5/6/2022 | View on chart |
| C | ▲ Buy | Grant | 1,179 | $66K | 4/1/2022 | View on chart |
| C | ▲ Buy | Grant | 314 | $18K | 4/1/2022 | View on chart |
| C | ▲ Buy | Grant | 22 | $1K | 4/1/2022 | View on chart |
| C | ▲ Buy | Grant | 2,255 | $0 | 2/10/2022 | View on chart |
| C | ▲ Buy | Grant | 1,067 | $66K | 1/1/2022 | View on chart |
| C | ▲ Buy | Grant | 36 | $2K | 1/1/2022 | View on chart |
| C | ▲ Buy | Grant | 257 | $16K | 1/1/2022 | View on chart |
| C | ▲ Buy | Grant | 940 | $66K | 10/1/2021 | View on chart |
| C | ▲ Buy | Grant | 218 | $15K | 10/1/2021 | View on chart |
| C | ▲ Buy | Grant | 32 | $2K | 10/1/2021 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 16, 2026
US presses China on Citigroup market access in Bangkok talks
The U.S. government has raised concerns about Citigroup's market access in China during bilateral talks in Bangkok. This diplomatic development highlights the ongoing regulatory and geopolitical risks associated with the bank's international operations. While Citi also initiated coverage on other companies like Mobileye, the trade discussions are the primary factor affecting the stock's broader outlook.
US presses China on Citigroup market access in Bangkok talks. The U.S. government has raised concerns about Citigroup's market access in China during bilateral talks in Bangkok. This diplomatic development highlights the ongoing regulatory and geopolitical risks associated with the bank's international operations. While Citi also initiated coverage on other companies like Mobileye, the trade discussions are the primary factor affecting the stock's broader outlook.